Chronic, Intermittent Microdoses of the Psychedelic N , N -Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works

A Simple Practice Guide for Dose Conversion between Animals and Human

Nair, A., & Jacob, S. (2016) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.177703 · Cited by 6,174 · see citing works

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006 · see citing works

A Neurotrophic Model for Stress-Related Mood Disorders

Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · see citing works

The novel object recognition memory: neurobiology, test procedure, and its modifications

Antunes, M., & Biala, G. (2012) · Cognitive Processing · doi:10.1007/s10339-011-0430-z · Cited by 2,390 · see citing works

Neurons in medial prefrontal cortex signal memory for fear extinction

Milad, M. R., & Quirk, G. J. (2002) · Nature · doi:10.1038/nature01138 · Cited by 1,836 · see citing works

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · see citing works

Psychedelics promote structural and functional neural plasticity

Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207 · see citing works

Administration of substances to laboratory animals: routes of administration and factors to consider.

Turner, P. V., Brabb, T., Pekow, C. A., & Vasbinder, M. A. (2011) · PubMed Central · Cited by 982 · see citing works

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932 · see citing works

Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons

Quirk, G. J., Likhtik, E., Pelletier, J. G., & Paré, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08800.2003 · Cited by 927 · see citing works

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

Carhart-Harris, R. L., & Goodwin, G. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.84 · Cited by 706 · see citing works

A prefrontal cortex–brainstem neuronal projection that controls response to behavioural challenge

Warden, M. R., Selimbeyoglu, A., Mirzabekov, J. J., Lo, M., Thompson, K. R., Kim, S.-Y., Adhikari, A., Tye, K. M., Frank, L. M., & Deisseroth, K. (2012) · Nature · doi:10.1038/nature11617 · Cited by 645 · see citing works

The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory

Hughes, R. N. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.06.006 · Cited by 641 · see citing works

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13282-7 · Cited by 587 · see citing works

Assessment of Social Interaction Behaviors

Kaidanovich‐Beilin, O., Lipina, T. V., Vukobradovic, I., Roder, J., & Woodgett, J. R. (2011) · Journal of Visualized Experiments · doi:10.3791/2473 · Cited by 550 · see citing works

Basomedial amygdala mediates top-down control of anxiety and fear

Adhikari, A., Lerner, T. N., Finkelstein, J., Pak, S., Jennings, J. H., Davidson, T. J., Ferenczi, E., Gunaydin, L. A., Mirzabekov, J. J., Ye, L., et al. (2015) · Nature · doi:10.1038/nature15698 · Cited by 485 · see citing works

5-HT_2AReceptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex

Vaidya, V. A., Marek, G. J., Aghajanian, G. K., & Duman, R. S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02785.1997 · Cited by 479 · see citing works

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453 · see citing works

Psychedelics as Medicines: An Emerging New Paradigm

Nichols, D. E., Johnson, M., & Nichols, C. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.557 · Cited by 373 · see citing works

Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: Relevance to emotionality and sex

Guilloux, J., Seney, M. L., Edgar, N. M., & Sibille, E. L. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.01.019 · Cited by 362 · see citing works

Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice

Fuentes, A., Pineda, M., & Venkata, K. C. N. (2018) · Pharmacy · doi:10.3390/pharmacy6020043 · Cited by 338 · see citing works

Antidepressant-Like Effects of Medial Prefrontal Cortex Deep Brain Stimulation in Rats

Hamani, C., Diwan, M., Macedo, C. E., Brandão, M. L., Shumake, J., Gonzalez-Lima, F., Raymond, R., Lozano, A. M., Fletcher, P. J., & Nobrega, J. N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.025 · Cited by 324 · see citing works

Neural correlates of the DMT experience assessed with multivariate EEG

Timmermann, C., Roseman, L., Schartner, M., Milliere, R., Williams, L. T. J., Erritzoe, D., Muthukumaraswamy, S., Ashton, M., Bendrioua, A., Kaur, O., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51974-4 · Cited by 315 · see citing works

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study.

Bouso, J. C., González, D., Fondevila, S., Cutchet, M., Fernández, X., Ribeiro Barbosa, P. C., Alcázar-Córcoles, M. Á., Araújo, W. S., Barbanoj, M. J., Fábregas, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042421 · Cited by 313 · see citing works

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. C. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316638008 · Cited by 306 · see citing works

Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex

González-Maeso, J., Yuen, T., Ebersole, B. J., Wurmbach, E., Lira, A., Zhou, M., Weisstaub, N., Hen, R., Gingrich, J. A., & Sealfon, S. C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08836.2003 · Cited by 297 · see citing works

The burden of brain diseases in Europe

Olesen, J., & Leonardi, M. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00682.x · Cited by 269 · see citing works

Neuropharmacology of N,N-dimethyltryptamine

Carbonaro, T. M., & Gatch, M. B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.016 · Cited by 268 · see citing works

Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions

Fuchikami, M., Thomas, A., Liu, R., Wohleb, E. S., Land, B. B., DiLeone, R. J., Aghajanian, G. K., & Duman, R. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414728112 · Cited by 265 · see citing works

Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior

Brachman, R. A., McGowan, J. C., Perusini, J. N., Lim, S. C., Pham, T. H., Faye, C., Gardier, A. M., Mendez‐David, I., David, D. J. P., Hen, R., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.022 · Cited by 258 · see citing works

Psychoplastogens: A promising class of plasticity-promoting neurotherapeutics

Olson, D. E. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518800508 · Cited by 257 · see citing works

Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA

Mithoefer, M. C., Grob, C. S., & Brewerton, T. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00576-3 · Cited by 239 · see citing works

A systematic study of microdosing psychedelics

Polito, V., & Stevenson, R. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211023 · Cited by 235 · see citing works

Abnormal mTOR Activation in Autism

Winden, K. D., Ebrahimi‐Fakhari, D., & Şahin, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061747 · Cited by 222 · see citing works

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans.

Bouso, J. C., Palhano-Fontes, F., Rodríguez-Fornells, A., Ribeiro, S., Sanches, R., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., & Riba, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.01.008 · Cited by 218 · see citing works

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research

Kuypers, K., Ng, L., Erritzoe, D., Knudsen, G., Nichols, C. D., Nichols, D. E., Pani, L., Soula, A., & Nutt, D. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119857204 · Cited by 188 · see citing works

Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting

Prochazkova, L., Lippelt, D. P., Colzato, L. S., Kuchar, M., Sjoerds, Z., & Hommel, B. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5049-7 · Cited by 177 · see citing works

Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers

Bershad, A. K., Schepers, S. T., Bremmer, M. P., Lee, R., & de Wit, H. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.019 · Cited by 175 · see citing works

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers

Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L.-A., Hui, K., Hapke, E., & Farb, N. A. S. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5106-2 · Cited by 174 · see citing works

Effects of <i>N</i>,<i>N</i>-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression

Cameron, L. P., Benson, C. J., Dunlap, L. E., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00134 · Cited by 171 · see citing works

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial

Yanakieva, S., Polychroni, N., Family, N., Williams, L. T. J., Luke, D. P., & Terhune, D. B. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5119-x · Cited by 167 · see citing works

Activation of mTOR: a culprit of Alzheimer&amp;rsquo;s disease?

Cai, Z., Zhou, Y., Xiao, M., Yan, L.-J., & He, W. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75717 · Cited by 161 · see citing works

Psychedelic Drugs in Biomedicine

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.003 · Cited by 155 · see citing works

Powerful substances in tiny amounts: An interview study of psychedelic microdosing

Johnstad, P. G. (2018) · Nordic Studies on Alcohol and Drugs · doi:10.1177/1455072517753339 · Cited by 155 · see citing works

Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors

Smith, R. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00110-5 · Cited by 147 · see citing works

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning

Young, M. B., Andero, R., Ressler, K. J., & Howell, L. L. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.138 · Cited by 141 · see citing works

Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans.

Strassman, R. J., Qualls, C. R., & Berg, L. M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00200-6 · Cited by 130 · see citing works

Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex

Muschamp, J. W., Regina, M. J., Hull, E. M., Winter, J. C., & Rabin, R. A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.044 · Cited by 119 · see citing works

Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT)

Cameron, L. P., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00101 · Cited by 117 · see citing works

Psychedelic Microdosing: Prevalence and Subjective Effects

Cameron, L. P., Nazarian, A., & Olson, D. E. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1718250 · Cited by 110 · see citing works

Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine

Dunlap, L. E., Andrews, A. M., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00155 · Cited by 106 · see citing works

Identification of Psychoplastogenic <i>N</i> , <i>N</i> -Dimethylaminoisotryptamine (isoDMT) Analogues through Structure–Activity Relationship Studies

Dunlap, L. E., Azinfar, A., Ly, C., Cameron, L. P., Viswanathan, J., Tombari, R. J., Myers-Turnbull, D., Taylor, J. C., Grodzki, A. C., Lein, P. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01404 · Cited by 95 · see citing works

Prophylactic Ketamine Attenuates Learned Fear

McGowan, J. C., LaGamma, C. T., Lim, S. C., Tsitsiklis, M., Neria, Y., Brachman, R. A., & Denny, C. A. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.19 · Cited by 90 · see citing works

Previous Ketamine Produces an Enduring Blockade of Neurochemical and Behavioral Effects of Uncontrollable Stress

Amat, J., Dolzani, S. D., Tilden, S. G., Christianson, J. P., Kubala, K. H., Bartholomay, K. L., Sperr, K., Ciancio, N., Watkins, L. R., & Maier, S. F. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3114-15.2016 · Cited by 79 · see citing works

In vivo metabolism of 5-methoxy-N, N-dimethyltryptamine and N,N-dimethyltryptamine in the rat

Sitaram, B. R., Lockett, L., Talomsin, R., Blackman, G. L., & McLeod, W. R. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90118-3 · Cited by 74 · see citing works

Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT 2 signalling

Buchborn, T., Schröder, H., Höllt, V., & Grecksch, G. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114531666 · Cited by 72 · see citing works

Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia

Martin, D. A., Marona-Lewicka, D., Nichols, D. E., & Nichols, C. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.013 · Cited by 67 · see citing works

An animal model of schizophrenia based on chronic LSD administration: Old idea, new results

Marona‐Lewicka, D., Nichols, C. D., & Nichols, D. E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.006 · Cited by 65 · see citing works

Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats

Horsley, R. R., Páleníček, T., Kolin, J., & Valeš, K. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000394 · Cited by 52 · see citing works

The Effects of Hallucinogens on Gene Expression

Martin, D. A., & Nichols, C. D. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_479 · Cited by 51 · see citing works

Predictability and heritability of individual differences in fear learning

Shumake, J., Furgeson-Moreira, S., & Monfils, M. (2014) · Animal Cognition · doi:10.1007/s10071-014-0752-1 · Cited by 49 · see citing works

Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats

Gatch, M. B., Rutledge, M. A., Carbonaro, T. M., & Forster, M. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1501-z · Cited by 38 · see citing works

Biphasic dose-response effects of N-N-dimethyltryptamine on the rat startle reflex

Davis, M. E., & Sheard, M. H. (1974) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(74)90116-6 · Cited by 33 · see citing works

Effects of serotonin1/2 receptor agonists on dark-phase food and water intake in rats

Schreiber, R., Selbach, K., Asmussen, M., et al. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00357-9 · Cited by 29 · see citing works

Reproductive effects of the psychoactive beverage ayahuasca in male Wistar rats after chronic exposure

Santos, A. D. F. A., Vieira, A. L. S., Pic‐Taylor, A., & Caldas, E. D. (2017) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2017.01.006 · Cited by 21 · see citing works

Reaction of N , N -Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions

Dunlap, L. E., & Olson, D. E. (2018) · ACS Omega · doi:10.1021/acsomega.8b00507 · Cited by 19 · see citing works

Effects of N,N-Dimethyltryptamine (DMT) and 5-Methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats

Walters, J. K., Sheard, M. H., & Davis, M. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90016-3 · Cited by 18 · see citing works

Severe aggression in rats induced by mescaline but not other hallucinogens

Sbordone, R. J., Wingard, J. A., Gorelick, D. A., et al. (1979) · Psychopharmacology · doi:10.1007/bf00428319 · Cited by 17 · see citing works

Effects of N, N-Dimethyltryptamine on behavioural habituation in the rat

File, S. E. (1977) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(77)90067-3 · Cited by 16 · see citing works

Observational Determination of Dose-Response Curves in Hallucinogen-Treated Monkeys

Brewster, J. M., Siegel, R. K., Johnson, C. A., et al. (2017) · International Pharmacopsychiatry · doi:10.1159/000468218 · Cited by 9 · see citing works

Disruption of conditioned avoidance behavior by N, N-dimethyltryptamine (DMT) and stereotype by β-phenylethylamine (PEA): Animal models of attentional defects in schizophrenia

Stoff, D. M., Moja, E. A., Gillin, J. C., et al. (1978) · Journal of Psychiatric Research · doi:10.1016/0022-3956(78)90025-0 · Cited by 4 · see citing works

The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects

Olson, D. E. (2021) · ACS Pharmacology &amp; Translational Science · doi:10.1021/acsptsci.0c00192 · Cited by 329 · see citing works

Towards an understanding of psychedelic-induced neuroplasticity

Calder, A. E., & Hasler, G. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01389-z · Cited by 313 · see citing works

Neural correlates of the DMT experience assessed with multivariate EEG

Timmermann, C., Roseman, L., Schartner, M., Milliere, R., Williams, L. T. J., Erritzoe, D., Muthukumaraswamy, S., Ashton, M., Bendrioua, A., Kaur, O., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51974-4 · Cited by 315 · see citing works

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics

Aleksandrova, L. R., & Phillips, A. G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.003 · Cited by 276 · see citing works

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works

Psychedelics and Other Psychoplastogens for Treating Mental Illness.

Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M., & Olson, D. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.727117 · Cited by 166 · see citing works

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing

Kaertner, L. S., Steinborn, M. B., Kettner, H., Spriggs, M. J., Roseman, L., Buchborn, T., Balaet, M., Timmermann, C., Erritzoe, D., & Carhart-Harris, R. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-81446-7 · Cited by 145 · see citing works

Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms

dos Santos, R. G., & Hallak, J. E. C. (2020) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.001 · Cited by 111 · see citing works

Psychedelic Microdosing: Prevalence and Subjective Effects

Cameron, L. P., Nazarian, A., & Olson, D. E. (2020) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2020.1718250 · Cited by 110 · see citing works

Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism

Meinhardt, M. W., Pfarr, S., Fouquet, G., Rohleder, C., Meinhardt, M. L., Barroso-Flores, J., Hoffmann, R., Jeanblanc, J., Paul, E., Wagner, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2399 · Cited by 89 · see citing works

Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study

Marschall, J., Fejer, G., Lempe, P., Prochazkova, L., Kuchar, M., Hajkova, K., & van Elk, M. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211050556 · Cited by 72 · see citing works

Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective

Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69 · see citing works

Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse

Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0694-z · Cited by 65 · see citing works

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT

Barker, S. A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06065-0 · Cited by 58 · see citing works

Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats

Colaço, C. S., Alves, S. S., Nolli, L. M., Pinheiro, W. O., de Oliveira, D. G. R., Santos, B. W. L., Pic-Taylor, A., Mortari, M. R., & Caldas, E. D. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00547-w · Cited by 58 · see citing works

Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action

dos Santos, R. G., Hallak, J. E., Baker, G., & Dursun, S. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120986422 · Cited by 55 · see citing works

Pharmahuasca and DMT rescue ROS production and differentially expressed genes observed after predator and psychosocial stress: Relevance to human PTSD

Kelley, D. P., Venable, K., Destouni, A., Billac, G., Ebenezer, P., Stadler, K., Nichols, C., Barker, S., & Francis, J. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00660 · Cited by 42 · see citing works

ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ

Атабекова, Б. Б. (2024) · Habaršy. Pedagogika ġylymdary seriâsy · doi:10.51889/2959-5762.2023.80.4.019

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

Personality correlates and utilitarian judgments in the everyday context: Psychopathic traits and differential effects of empathy, social dominance orientation, and dehumanization beliefs

Takamatsu, R. (2019) · Personality and Individual Differences · doi:10.1016/j.paid.2019.03.029 · Cited by 22 · see citing works

Amount of altruistic punishment accounts for subsequent emotional gratification in participants with primary psychopathy

Masui, K., Iriguchi, S., Nomura, M., & Ura, M. (2011) · Personality and Individual Differences · doi:10.1016/j.paid.2011.07.006 · Cited by 14 · see citing works